Suppr超能文献

评估非洲裔裔女性乳腺癌的多基因风险评分。

Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry.

机构信息

Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

出版信息

J Natl Cancer Inst. 2021 Sep 4;113(9):1168-1176. doi: 10.1093/jnci/djab050.

Abstract

BACKGROUND

Polygenic risk scores (PRSs) have been demonstrated to identify women of European, Asian, and Latino ancestry at elevated risk of developing breast cancer (BC). We evaluated the performance of existing PRSs trained in European ancestry populations among women of African ancestry.

METHODS

We assembled genotype data for women of African ancestry, including 9241 case subjects and 10 193 control subjects. We evaluated associations of 179- and 313-variant PRSs with overall and subtype-specific BC risk. PRS discriminatory accuracy was assessed using area under the receiver operating characteristic curve. We also evaluated a recalibrated PRS, replacing the index variant with variants in each region that better captured risk in women of African ancestry and estimated lifetime absolute risk of BC in African Americans by PRS category.

RESULTS

For overall BC, the odds ratio per SD of the 313-variant PRS (PRS313) was 1.27 (95% confidence interval [CI] = 1.23 to 1.31), with an area under the receiver operating characteristic curve of 0.571 (95% CI = 0.562 to 0.579). Compared with women with average risk (40th-60th PRS percentile), women in the top decile of PRS313 had a 1.54-fold increased risk (95% CI = 1.38-fold to 1.72-fold). By age 85 years, the absolute risk of overall BC was 19.6% for African American women in the top 1% of PRS313 and 6.7% for those in the lowest 1%. The recalibrated PRS did not improve BC risk prediction.

CONCLUSION

The PRSs stratify BC risk in women of African ancestry, with attenuated performance compared with that reported in European, Asian, and Latina populations. Future work is needed to improve BC risk stratification for women of African ancestry.

摘要

背景

多基因风险评分(PRS)已被证明可识别欧洲、亚洲和拉丁裔血统的女性,使她们处于乳腺癌(BC)高发风险中。我们评估了在非洲裔女性中,基于欧洲血统人群训练的现有 PRS 的表现。

方法

我们收集了非洲裔女性的基因型数据,包括 9241 例病例和 10193 例对照。我们评估了 179 变体和 313 变体 PRS 与整体和亚型特异性 BC 风险的相关性。使用接受者操作特征曲线下面积评估 PRS 的判别准确性。我们还评估了经过重新校准的 PRS,用在非洲裔女性中更好地捕获风险的每个区域的变异体替代索引变异体,并按 PRS 类别估计非裔美国人的 BC 终生绝对风险。

结果

对于整体 BC,313 变体 PRS(PRS313)每标准差的优势比为 1.27(95%置信区间[CI] = 1.23 至 1.31),接受者操作特征曲线下面积为 0.571(95%CI = 0.562 至 0.579)。与风险处于平均水平(PRS 百分位数 40-60)的女性相比,PRS313 最高十分位数的女性风险增加了 1.54 倍(95%CI = 1.38 倍至 1.72 倍)。在 85 岁时,PRS313 最高 1%的非裔美国女性总体 BC 的绝对风险为 19.6%,而最低 1%的女性绝对风险为 6.7%。经重新校准的 PRS 并未改善 BC 风险预测。

结论

PRS 可对非洲裔女性的 BC 风险进行分层,但与欧洲、亚洲和拉丁裔人群报告的结果相比,其性能有所减弱。需要进一步的研究来改善非洲裔女性的 BC 风险分层。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验